EA017566B1 - Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины - Google Patents

Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины Download PDF

Info

Publication number
EA017566B1
EA017566B1 EA201000708A EA201000708A EA017566B1 EA 017566 B1 EA017566 B1 EA 017566B1 EA 201000708 A EA201000708 A EA 201000708A EA 201000708 A EA201000708 A EA 201000708A EA 017566 B1 EA017566 B1 EA 017566B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
compound according
treatment
cooh
cells
Prior art date
Application number
EA201000708A
Other languages
English (en)
Russian (ru)
Other versions
EA201000708A1 (ru
Inventor
Джанкарло Наккари
Серджо Барони
Original Assignee
Джулиани Интернэшнл Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37579831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA017566(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Джулиани Интернэшнл Лимитед filed Critical Джулиани Интернэшнл Лимитед
Publication of EA201000708A1 publication Critical patent/EA201000708A1/ru
Publication of EA017566B1 publication Critical patent/EA017566B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
EA201000708A 2005-07-22 2006-07-24 Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины EA017566B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000389A ITRM20050389A1 (it) 2005-07-22 2005-07-22 Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

Publications (2)

Publication Number Publication Date
EA201000708A1 EA201000708A1 (ru) 2010-10-29
EA017566B1 true EA017566B1 (ru) 2013-01-30

Family

ID=37579831

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201000708A EA017566B1 (ru) 2005-07-22 2006-07-24 Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины
EA200800372A EA014665B3 (ru) 2005-07-22 2006-07-24 Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200800372A EA014665B3 (ru) 2005-07-22 2006-07-24 Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины

Country Status (23)

Country Link
US (6) US8153841B2 (enExample)
EP (1) EP1910270B3 (enExample)
JP (1) JP5312026B2 (enExample)
KR (1) KR101317519B1 (enExample)
CN (2) CN102020577B (enExample)
AU (1) AU2006271165C1 (enExample)
CA (1) CA2616146C (enExample)
CY (1) CY1114294T1 (enExample)
DK (1) DK1910270T6 (enExample)
EA (2) EA017566B1 (enExample)
ES (1) ES2421260T7 (enExample)
HR (1) HRP20130549T4 (enExample)
IL (2) IL188878A (enExample)
IT (1) ITRM20050389A1 (enExample)
MX (1) MX366596B (enExample)
NO (1) NO340680B1 (enExample)
NZ (2) NZ566045A (enExample)
PL (1) PL1910270T6 (enExample)
PT (1) PT1910270E (enExample)
SI (1) SI1910270T1 (enExample)
UA (1) UA100359C2 (enExample)
WO (1) WO2007010516A2 (enExample)
ZA (2) ZA200801671B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
IE20070129A1 (en) * 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
ITMI20072429A1 (it) 2007-12-24 2009-06-25 Giuliani Int Ltd Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
UA107562C2 (uk) * 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EP2805746B1 (en) * 2009-02-16 2020-05-06 Nogra Pharma Limited Alkylamido compounds and uses thereof
CN102906074A (zh) 2010-05-24 2013-01-30 东亚荣养株式会社 稠合咪唑衍生物
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
AU2013248397A1 (en) 2012-04-18 2014-10-02 Nogra Pharma Limited Methods of treating lactose intolerance
FR2996545B1 (fr) 2012-10-08 2016-03-25 Ecole Polytech Procede microfluidique de traitement et d'analyse d'une solution contenant un materiel biologique, et circuit microfluidique correspondant.
WO2015141851A1 (ja) * 2014-03-20 2015-09-24 京セラ株式会社 ユーザ端末、通信制御方法及び基地局
WO2017093444A1 (en) * 2015-12-01 2017-06-08 Nogra Pharma Limited Compositions for oral administration in the treatment of inflammatory bowel disease
WO2020152350A1 (en) 2019-01-25 2020-07-30 Nogra Pharma Limited Compositions for use in preventing acne
SI3921299T1 (sl) 2019-02-08 2025-03-31 Nogra Pharma Limited Postopek izdelave 3-(4'-aminofenil)-2-metoksipropionske kisline in njenih analogov in vmesnih proizvodov
WO2025132838A1 (en) 2023-12-20 2025-06-26 Nogra Pharma Limited Acne topical formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055689A1 (de) * 1980-12-22 1982-07-07 Schering Aktiengesellschaft In 3-Stellung substituierte 2,4,6-trihalogenierte Benzamide und deren Salze, deren Herstellung und Verwendung als Ersatzstoffe für natürliche Süssstoffe sowie Süssungsmittel auf Basis dieser Verbindungen
EP1285908A1 (en) * 2000-05-29 2003-02-26 Kyorin Pharmaceutical Co., Ltd. Substituted phenylpropionic acid derivatives

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
US3211610A (en) 1961-09-29 1965-10-12 Merck & Co Inc Benzoic acid ester derivatives for treating coccidiosis and method of using same
US3444232A (en) 1966-05-18 1969-05-13 Squibb & Sons Inc O-alkyl or phenylalkyl benzohydroxamic acids
GB1359560A (en) 1972-02-25 1974-07-10 Merck & Co Inc Preparation of pyrrylsalicylic acid
US4036951A (en) 1973-03-12 1977-07-19 Synergistics, Inc. Ultra-violet filtration with certain aminosalicylic acid esters
FR2440353A1 (fr) * 1978-11-03 1980-05-30 Science Union & Cie Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
US4348223A (en) * 1980-12-05 1982-09-07 Ppg Industries, Inc. N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides
JPS58194814A (ja) 1982-05-11 1983-11-12 Nippon Shinyaku Co Ltd 免疫調節作用を有する薬剤
IL69282A (en) 1982-09-02 1988-06-30 Euro Celtique Sa Method for the carboxylation of potassium phenoxide with carbon dioxide
DE3786452T2 (de) * 1987-02-05 1993-10-21 Kureha Chemical Ind Co Ltd Benzylether-Verbindungen und Verfahren zu ihrer Herstellung.
US4933330A (en) 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
ATE113209T1 (de) 1988-05-05 1994-11-15 Tillotts Pharma Ag Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
WO1992006690A1 (en) 1990-10-22 1992-04-30 Borody Thomas J Treatment of non-inflammatory and non-infectious bowel disorders
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5262549A (en) 1991-05-30 1993-11-16 Polaroid Corporation Benzpyrylium dyes, and processes for their preparation and use
US5302751A (en) 1992-01-21 1994-04-12 Ethyl Corporation Profen resolution
WO1994000135A1 (en) 1992-06-30 1994-01-06 Shapiro Howard K Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
CA2190107A1 (en) 1994-05-11 1995-11-23 Howard K. Shapiro Compositions for treatment of chronic inflammatory diseases
US5594015A (en) 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
HUP9900309A3 (en) 1995-03-28 1999-11-29 Janssen Pharmaceutica Nv Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
GB9600464D0 (en) 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
GB9617001D0 (en) 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
DE19647582A1 (de) 1996-11-18 1998-05-20 Hoechst Ag Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane
WO1998043081A1 (en) 1997-03-26 1998-10-01 Ligand Pharmaceuticals Incorporated Treatment of gastrointestinal disease with ppar modulators
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
AU9002798A (en) * 1997-09-19 1999-04-12 Ono Pharmaceutical Co. Ltd. Fused or nonfused benzene compounds
FR2773075B1 (fr) 1997-12-31 2000-05-05 Cird Galderma Utilisation d'activateurs de ppar-gamma en dermatologie
US6114382A (en) 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
FR2791671B1 (fr) 1999-04-01 2001-05-11 Oreal Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation
US20040034067A1 (en) 1999-04-15 2004-02-19 Macphee Colin Houston Novel method of treatment
GB9908647D0 (en) 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel compounds
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
TWI262185B (en) 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
CA2656216C (en) 2000-04-19 2012-01-24 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
US7049342B2 (en) 2000-05-29 2006-05-23 Kyorin Pharmaceutical Co., Ltd. Substituted phenylpropionic acid derivatives
DE60115465T2 (de) 2000-08-29 2006-08-03 Nobex Corp. Immunoregulierende verbindungen, deren derivate und ihre verwendung
AU2002222574A1 (en) 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
FR2822955B1 (fr) 2001-03-27 2003-10-03 Chru Lille Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
JP2004528329A (ja) 2001-04-18 2004-09-16 メルク　エンド　カムパニー　インコーポレーテッド 炎症を処置するためのＰＰＡＲα〜γのリガンドまたはアゴニスト
CA2354921A1 (en) 2001-05-24 2002-11-24 Yasuo Konishi Drug evolution: drug design at hot spots
CN1589258A (zh) * 2001-10-16 2005-03-02 雷迪实验室有限公司 新的β－苯基－α－氧取代的丙酸衍生物,它的制备方法和它们制备药学上重要的化合物的应用
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
UA82835C2 (en) 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20030113815A1 (en) 2001-12-19 2003-06-19 Pfizer Inc. Canine peroxisome proliferator activated receptor gamma
US20030220374A1 (en) 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20040115127A1 (en) 2002-04-12 2004-06-17 Wright Samuel D. Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
GB0303609D0 (en) 2003-02-17 2003-03-19 Glaxo Group Ltd Novel therapeutic method and compositions
US20060159648A1 (en) 2003-02-17 2006-07-20 Davis Adrian F Novel therapeutic method and compositions for topical administration
JPWO2004082715A1 (ja) 2003-03-20 2006-06-22 エーザイ株式会社 炎症性腸疾患治療剤としての併用医薬
JP5198768B2 (ja) 2003-07-21 2013-05-15 メルク セローノ ソシエテ アノニム アルキニルアリールカルボキサミド
GB2422782A (en) 2003-10-21 2006-08-09 Inspire Pharmaceuticals Inc Non-nucleotide compositions and method for treating pain
US20070093476A1 (en) * 2003-10-28 2007-04-26 Bhunia Debnath Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
EP1691806A2 (en) 2003-12-03 2006-08-23 Smithkline Beecham Corporation Novel therapeutic method and compositions
CA2553775A1 (en) 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
WO2005084658A1 (en) 2004-03-04 2005-09-15 Arakis Ltd. Derivatives of actarit and their therapeutic use
US20060286046A1 (en) 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
US20060270635A1 (en) 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
ITRM20050389A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
DE102005061472A1 (de) 2005-12-22 2007-07-05 Saltigo Gmbh Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren
WO2007096148A1 (en) 2006-02-23 2007-08-30 Lipid Nutrition B.V. Immunoregulation
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
IE20070129A1 (en) 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
WO2009025854A1 (en) 2007-08-22 2009-02-26 Burnham Institute For Medical Research Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
ITMI20072429A1 (it) 2007-12-24 2009-06-25 Giuliani Int Ltd Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
US8030520B2 (en) 2008-03-31 2011-10-04 Saltigo Gmbh Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EP2805746B1 (en) 2009-02-16 2020-05-06 Nogra Pharma Limited Alkylamido compounds and uses thereof
EP2298321A1 (en) 2009-08-26 2011-03-23 Nordic Pharma Novel pharmaceutical compositions for treating IBD
EP2731605A4 (en) 2011-07-15 2015-02-25 Sla Pharma Ag PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION
EP2773378B1 (en) 2011-10-31 2016-08-10 Larsen, Claus Selch Prodrugs of non-steroid anti-inflammatory agents (nsaids)
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
AU2013248397A1 (en) 2012-04-18 2014-10-02 Nogra Pharma Limited Methods of treating lactose intolerance
IN2014DN10214A (enExample) 2012-06-01 2015-08-07 Nogra Pharma Ltd
US9013997B2 (en) 2012-06-01 2015-04-21 Broadcom Corporation System for performing distributed data cut-through
EP2897603A1 (en) 2012-09-13 2015-07-29 Nogra Pharma Limited Methods of inhibiting hair growth
NZ705389A (en) 2012-09-13 2018-08-31 Nogra Pharma Ltd Methods of treating hair related conditions
WO2016154730A1 (en) 2015-04-02 2016-10-06 University Health Network Gut anti-inflammatory agents for regulation of high blood glucose levels
JP6798075B2 (ja) 2015-06-15 2020-12-09 エヌエムディー ファーマ エー／エス 神経筋障害を処置するのにおける使用のための化合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055689A1 (de) * 1980-12-22 1982-07-07 Schering Aktiengesellschaft In 3-Stellung substituierte 2,4,6-trihalogenierte Benzamide und deren Salze, deren Herstellung und Verwendung als Ersatzstoffe für natürliche Süssstoffe sowie Süssungsmittel auf Basis dieser Verbindungen
US4429152A (en) * 1980-12-22 1984-01-31 Schering, Aktiengesellschaft 3-Substituted 2,4,6-trihalogenated benzamides as sweetening agents
EP1285908A1 (en) * 2000-05-29 2003-02-26 Kyorin Pharmaceutical Co., Ltd. Substituted phenylpropionic acid derivatives

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ALLGAYER H.: "REVIEW ARTICLE: MECHANISMS OF ACTION OF MESALAZINE IN PREVENTING COLORECTAL CARCINOMA IN INFLAMMATORY BOWEL DISEASE", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, BLACKWELL SCIENTIFIC PUBLICATIONS LTD., CAMBRIDGE, GB, vol. 18, no. SUPPL 2, 2003, pages 10-14, XP008046292, ISSN: 0269-2813, the whole document *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414322, retrieved from XFIRE, Database accession no. brn 3200601, abstract & J. CHEM SOC, 1935, page 104, 111 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414323, retrieved from XFIRE, Database accession no. brn 3242057, abstract & CHEM BER, vol. 74, 1941, page 500, 517 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414324, retrieved from XFIRE, Database accession no. brn 3199917, abstract & CHEM BER, vol. 46, 1913, page 288 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414325, retrieved from XFIRE, Database accession no. brn 3199913, abstract & CHEM BER, vol. 46, 1913, page 3978 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414326, retrieved from XFIRE, Database accession no. brn 3296969, abstract & CHEM NEWS J IND SCI, vol. 36, 1877, page 269 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414327, retrieved from XFIRE, Database accession no. pcrn 859019, abstract & US 4429152 A (SCHERING AG [DE]), 31 January 1984 (1984-01-31) *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414328, retrieved from XFIRE, Database accession no. brn 3268495, abstract & JUSTUS LIEBIGS ANN CHEM, vol. 436, 1924, page 60 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414329, retrieved from XFIRE, Database accession no. brn 2208094, abstract & J AM CHEM SOC, vol. 68, 1946, page 2335, 2338 *
DATABASE BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002414330, retrieved from XFIRE, Database accession no. brn 2803076, abstract & J ORG CHEM, vol. 14, 1949, page 1013, 1018 *
ROUSSEAUX ET AL.: "Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome poliferator-activated receptor-gamma", JEM, vol. 201, no. 8, 18 April 2005 (2005-04-18), pages 1205-1215, XP002414312, cited in the application, the whole document *

Also Published As

Publication number Publication date
US8710100B2 (en) 2014-04-29
CN102020577B (zh) 2013-03-13
WO2007010516A2 (en) 2007-01-25
MX366596B (es) 2019-07-15
NO340680B1 (no) 2017-05-29
IL205992A (en) 2014-05-28
AU2006271165B2 (en) 2012-01-19
CA2616146A1 (en) 2007-01-25
ITRM20050389A1 (it) 2007-01-23
WO2007010516A3 (en) 2007-03-29
EP1910270A2 (en) 2008-04-16
NO20080325L (no) 2008-04-16
ES2421260T3 (es) 2013-08-30
JP5312026B2 (ja) 2013-10-09
IL188878A (en) 2013-04-30
NZ592228A (en) 2012-10-26
US10016381B2 (en) 2018-07-10
BRPI0613396A2 (pt) 2011-01-11
EP1910270B3 (en) 2016-05-11
KR20080039428A (ko) 2008-05-07
US20170312239A1 (en) 2017-11-02
DK1910270T6 (en) 2016-08-29
ZA201008268B (en) 2012-04-25
EA201000708A1 (ru) 2010-10-29
US20150265563A1 (en) 2015-09-24
DK1910270T3 (da) 2013-07-01
EA200800372A1 (ru) 2008-06-30
CN101243039A (zh) 2008-08-13
US9345680B2 (en) 2016-05-24
BRPI0613396A8 (pt) 2017-12-26
US20130005813A1 (en) 2013-01-03
NZ566045A (en) 2012-04-27
US8153841B2 (en) 2012-04-10
HRP20130549T4 (hr) 2016-07-15
HRP20130549T1 (en) 2013-07-31
AU2006271165C1 (en) 2016-11-17
EP1910270B1 (en) 2013-05-08
UA100359C2 (uk) 2012-12-25
SI1910270T1 (sl) 2013-08-30
US9561202B2 (en) 2017-02-07
EA014665B1 (ru) 2010-12-30
EA014665B3 (ru) 2016-09-30
PL1910270T3 (pl) 2013-09-30
US9133099B2 (en) 2015-09-15
PT1910270E (pt) 2013-07-17
CN102020577A (zh) 2011-04-20
PL1910270T6 (pl) 2017-05-31
ES2421260T7 (es) 2016-10-11
IL188878A0 (en) 2008-04-13
AU2006271165A1 (en) 2007-01-25
CN101243039B (zh) 2013-04-03
US20150045436A1 (en) 2015-02-12
JP2009502777A (ja) 2009-01-29
US20090048343A1 (en) 2009-02-19
US20150265562A1 (en) 2015-09-24
CA2616146C (en) 2015-06-30
KR101317519B1 (ko) 2013-10-15
CY1114294T1 (el) 2016-08-31
ZA200801671B (en) 2011-02-23

Similar Documents

Publication Publication Date Title
US10016381B2 (en) Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
JP5940982B2 (ja) アンドロゲンレセプター活性調節因子としての、ビスフェノール誘導体およびその使用
US8450506B2 (en) Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field
Liu et al. Novel allosteric inhibitors of deoxyhypusine synthase against malignant melanoma: design, synthesis, and biological evaluation
Yang et al. Improved synthesis and impurity identification of (R)-lacosamide
BRPI0613396B1 (pt) Composto, uso do mesmo, e, composição farmacêutica
Ju et al. Exploration of new azole derivatives containing ethanolamine moiety as anti-UC agents by inhibiting NF-κB/MAPK pathways

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent